

Cagrilintide
Dispatching Next Week
Get notified when this item is available for immediate dispatch
✓Free shipping on orders over $199 AUD
✓Australia Post tracked — Standard $8.99 / Express $13.99
✓Same-day dispatch on orders placed before 12PM AEST (next business day after)
Product Details
Amylin-Pathway Metabolic Research
Cagrilintide is available in Australia from Peptide Warehouse Australia with fast domestic shipping to all states and territories.
Cagrilintide (AM833) is a long-acting acylated analogue of the pancreatic hormone amylin. It is studied in metabolic research as a tool for investigating amylin-receptor and calcitonin-receptor signalling and their role in satiety and energy-balance pathways. Its acylation profile gives it an extended half-life relative to native amylin, making it a useful long-acting research probe.
Cagrilintide is frequently studied alongside GLP-1 receptor agonists in research examining complementary metabolic pathways (the amylin + GLP-1 combination is an active area of preclinical investigation).
What Cagrilintide Is Studied For
- ✓Satiety signalling — Studied for amylin-receptor engagement and its role in energy-intake research models.
- ✓Energy balance — Investigated for effects on body-weight regulation pathways in preclinical settings.
- ✓Receptor pharmacology — Studied for binding across the amylin and calcitonin receptor families.
- ✓Combination research — Researched alongside incretin compounds for complementary metabolic-pathway activity.
⚠ For in-vitro laboratory research use only. Not approved for human or veterinary use. Not drugs, food supplements, or cosmetics. Not evaluated or approved by the TGA. You must be 18 years of age or older to purchase. By placing this order, you confirm you are a qualified researcher and will use this compound strictly in accordance with all applicable Australian laws and regulations.
Specifications
| Purity | ≥99% (HPLC) |
|---|---|
| Format | Lyophilized powder |
| Testing | HPLC purity + mass spectrometry identity, COA verified |
| Storage | Lyophilised: −20°C · Reconstituted: 2–8°C, use within 28 days |
| Research Use | In-vitro laboratory research use only |
Frequently Asked Questions — Cagrilintide
Cagrilintide (AM833) is a long-acting acylated analogue of amylin, a hormone co-secreted with insulin by pancreatic beta cells. In preclinical research it is studied for engagement of amylin and calcitonin receptors, satiety and energy-intake signalling, and body-weight regulation pathways in metabolic models. Its fatty-acid acylation extends its half-life compared with native amylin, making it a long-acting research probe. Supplied at ≥99% HPLC purity for in-vitro research use only.
A significant area of metabolic research examines amylin-pathway compounds in combination with GLP-1 receptor agonists, because the two engage distinct but complementary energy-balance pathways. In research settings each compound is reconstituted separately and combined at the point of use according to the experimental protocol. Researchers should consult the published literature for appropriate concentration ratios. Cagrilintide and GLP-1 agonists are distinct research tools and are not interchangeable. Not for human consumption — for research use only.
No. Cagrilintide is an investigational research compound and is not a registered pharmaceutical product in Australia — it is not stocked at retail pharmacies such as Chemist Warehouse and has not been approved for human use by the TGA. Peptide Warehouse Australia supplies Cagrilintide exclusively as a lyophilised powder for in-vitro laboratory research purposes. Not for human consumption — for research use only.
Reconstitution: Add 1–2mL of bacteriostatic water slowly down the inside wall of the vial using a 31G syringe and swirl gently until dissolved; do not shake. A 5mg vial reconstituted with 1mL BAC water yields a 5mg/mL solution. Storage: Lyophilised — store at −20°C for up to 24 months. Reconstituted — refrigerate at 2–8°C and use within 4 weeks, protected from light. BAC water is available at /products/bac-water-10ml. Not for human consumption — for research use only.
Legal status: Cagrilintide is legal to purchase in Australia for legitimate laboratory research purposes. It is not for human consumption, therapeutic, cosmetic, or veterinary use and is not TGA-approved. Purchasers must be 18+ and confirm research-only intent. Quality: each batch is independently verified by third-party HPLC at ≥99% purity with a full COA including HPLC purity %, mass spectrometry identity confirmation, and sterility screening. Full COAs are available in our COA Library.
Peptide Warehouse Australia stocks Cagrilintide 5mg and ships nationwide via Australia Post with full tracking. Orders placed before 12PM AEST dispatch the same business day from our Melbourne warehouse; orders after 12PM AEST dispatch the next business day. Standard Post $8.99 (2–6 business days); Express Post $13.99 (1–3 business days); free shipping on all orders over $199 AUD. All orders ship in discreet plain packaging with no external branding. Not for human consumption — for research use only.
Cagrilintide is a long-acting analogue of amylin, a hormone co-secreted with insulin, and is studied for engagement of amylin and calcitonin receptors involved in satiety and energy-balance signalling in research models. Its acylation extends its half-life relative to native amylin. Not for human consumption — for research use only.
An active area of metabolic research pairs Cagrilintide with the GLP-1 agonist semaglutide (a combination referred to in research as CagriSema) to study complementary amylin and incretin pathways. This combination research is a prominent reason Cagrilintide is studied. Not for human consumption — for research use only.
Cagrilintide acts on amylin/calcitonin receptors, a pathway distinct from the incretin (GLP-1/GIP) receptors targeted by compounds like semaglutide or tirzepatide. This is why it is studied as a complementary, not interchangeable, metabolic research tool. Not for human consumption — for research use only.
Cagrilintide is acylated to extend its duration of action substantially relative to native amylin, supporting long-acting research applications. Working concentrations and intervals depend on the protocol and should be drawn from the literature. Not for human consumption — for research use only.
Customers Also Purchase


Tesamorelin
Research-grade Tesamorelin 10mg lyophilised powder — 99.1% HPLC purity, COA verified. Stabilised GHRH analogue studied for visceral fat reduction, body recomposition, and GH/IGF-1 axis research. Distinct mechanism from GLP-1 compounds — works via endogenous GH stimulation.
Free shipping over $199

L-Carnitine
Research-grade L-Carnitine 500mg lyophilised powder — 99.0% HPLC purity, COA verified. Essential mitochondrial fatty acid transport cofactor — studied in beta-oxidation, CPT1 enzyme assays, acylcarnitine profiling, and energy metabolism research.
Free shipping over $199


AOD-9604
AOD-9604 — modified hGH(176-191) fragment studied in lipid-metabolism research. ≥99% HPLC purity, COA verified.
Free shipping over $199

5-Amino-1MQ
5-Amino-1MQ — small-molecule NNMT inhibitor studied in adipocyte and metabolic research. ≥98% HPLC purity, COA verified.
Free shipping over $199
Research Articles
Retatrutide vs Tirzepatide vs Semaglutide
A technical comparison of three GLP-1 receptor-targeting compounds: single, dual, and triple agonist mechanisms in preclinical and clinical research.
Compare compounds →Best Fat Loss Research Peptides in Australia (2026)
A comprehensive research overview of the leading GLP-1, GIP, and glucagon receptor agonist peptides available in Australia for metabolic and fat loss research in 2026.
Read full article →How to Reconstitute Peptides: A Step-by-Step Guide
Learn the correct technique for reconstituting lyophilised research peptides using bacteriostatic water for accurate, contamination-free preparations.
Step-by-step guide →Part of our
Metabolic Research research collection →Or use our Peptide Calculator to work out reconstitution and syringe units for this compound.
Pricing, stock, and COA last verified June 2026